Arcutis grants 58,500 RSUs, 17,000 stock options to six new employees
ARQT•Arcutis Biotherapeutics granted six new employees 58,500 restricted stock units and options to buy 17,000 shares on November 2, 2026, under its 2022 Inducement Plan.
1. Award terms
The restricted stock units vest over four years, with 25% vesting on each annual anniversary of the vesting commencement date. The options have a ten-year term and a $31.26 exercise price; 25% vest on the first anniversary, with the rest vesting in equal monthly installments over the following three years. All awards require continued employment through applicable vesting dates.
